Shree Ganesh Remedies Ltd.
Shree Ganesh Remed.
₹ 0.00
0.00 (0.00)%
NSE
BSE
Healthcare
Small-cap - With a market cap of ₹6.61 Cr.
| EX-Date | Purpose |
|---|---|
| 03 05 2021 | Final Dividend & Audited Results |
| 13 07 2021 | Quarterly Results Inter alia, to consider and approve the Unaudited Financial Results of the Company for the quarter ended on June 30, 2021. |
| 18 09 2021 | Bonus issue |
| 27 10 2021 | Quarterly Results |
| 19 11 2021 | Inter alia, to consider and approve the proposal for raising of funds by issuance of equity shares and/or convertible bonds and/or debentures and/or any other securities, through permissible modes including but not limited to a rights issue, preferential issue or qualified institutions placement, as may be permitted under applicable law and subject to such regulatory/ statutory approvals, as may be required. |
| 18 01 2022 | Quarterly Results |
| 06 05 2022 | Audited Results & Dividend |
| 12 07 2022 | Quarterly Results |
| 23 10 2022 | Quarterly Results |
| 16 01 2023 | Quarterly Results |
| 24 01 2023 | Rights Issue |
| 05 05 2023 | Final Dividend & Audited Results |
| 26 05 2023 | Final Dividend (Revised) & Audited Results |
| 30 05 2023 | Final Dividend (Revised) & Audited Results |
| 31 07 2023 | Quarterly Results |
| 10 11 2023 | Quarterly Results |
| 25 01 2024 | Rights Issue & Inter alia, to consider the first and final call on the outstanding 8,40,471 (Eight Lakhs Forty Thousand Four Hundred Seventy-One) partly paidup equity shares of the Company. |
| 12 02 2024 | Quarterly Results |
| 28 09 2024 | Inter alia, to consider forfeiture of Partly Paid-up Equity Shares issued on Right s basis, on which the holders thereof have failed to pay the balance call money within the stipulated timeline. |
| 29 10 2024 | Quarterly Results |
| 05 02 2025 | Quarterly Results |
| 19 05 2025 | Audited Results |
| 07 11 2025 | Quarterly Results |
| 23 01 2026 | Quarterly Results |
